1. ALLA AKTIER
  2. NYHETER
  3. NEWBURY PHARMACEUTICALS

Newbury Pharmaceuticals

Nyheter Newbury Pharmaceuticals Nyheter alla bolag

Newbury Pharmaceuticals expands the team with a Head of Business Development

Newbury Pharmaceuticals is pleased to announce the appointment of Mrs. Andrea Karnitschky as Senior Director and Head of Business Development. From August 1st 2022, Andrea Karnitschky’s responsibilities include the expansion of the pipeline and the development of strategic partnerships.

“We are very pleased to strengthen our team with Andrea who has an impressive track record in deal making. Andrea will be an important addition to Newbury, and I look forward to the collaboration to further grow our strong pipeline with new products and new exciting business opportunities”, says Lars Minor, CEO, Newbury Pharmaceuticals.

Prior to joining Newbury, Andrea Karnitschky held a position as Director & Head of In-licensing Europe at Dr. Reddy´s Laboratories SA following an appointment as Head of Sourcing at betapharm Arzneimittel GmbH. Andrea Karnitschky has a broad and deep network within the global pharmaceutical industry.

“I am excited to join Newbury – a young, dynamic, entrepreneurial company with high ambitions. It will be an interesting challenge to contribute to the growth of Newbury.” says Andrea Karnitschky.

For more information, contact:

Lars Minor, CEO
lars.minor@newburypharma.com
Mobile: +46 72-377 3005

www.newburypharma.com

About Newbury Pharmaceuticals

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products with focus on specialty and branded products in the Nordics. Newbury aims to make a difference by offering treatment solutions within areas like oncology, rare diseases and neurology. The portfolio is built by leveraging experience and extensive international network. Newbury offers strategic partnerships of innovation for the benefit of the Nordic healthcare market.

Västra Hamnen Corporate Finance is the Company's Certified Adviser on Nasdaq First North and can be reached at ca@vhcorp.se or +46 (0) 40 200 250.

Attachments

Newbury Pharmaceuticals expands the team with a Head of Business Development

Datum 2022-08-02, kl 14:30
Källa MFN
Bifogade filer
Newbury Pharmaceuticals expands the team with a Head of Business Development
Affiliate
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.